Effects of Alternate Nostril Breathing and Bellows Breath in COPD Patients (NCT07719192) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Effects of Alternate Nostril Breathing and Bellows Breath in COPD Patients
Pakistan54 participantsStarted 2026-06
Plain-language summary
COPD is a common respiratory disease characterized by progressive airflow obstruction, dyspnea, chronic cough, and sputum production. Alternate nostril breathing and bellows breath are pranayama-based breathing techniques that may improve respiratory function and overall well-being. This randomized clinical trial aims to compare the effects of these techniques on sputum clearance, pulmonary function tests, and quality of life in COPD patients. The study will be conducted at Punjab Institute of Cardiology using convenient sampling. Participants will be divided into two groups: Group A will perform alternate nostril breathing, while Group B will perform bellows breath exercises for 15-20 minutes daily over 3-4 weeks. Outcome measures include sputum clearance, spirometry, and quality of life questionnaires. Data will be analyzed using SPSS with significance set at p \< 0.05. The study may support the use of cost-effective, noninvasive breathing techniques for improving pulmonary function and quality of life in COPD patients.
Who can participate
Age range
10 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* diagnosed case of copd patients
* Age group:above 10 years
* Clinically stable
* Able to understand or perform breathing exercise
Exclusion Criteria:
* current acute pulmonary infection
* History of pneumothorax or hemoptysis
* Patients who was in stage 4 of functional classification of fatigue,palpation,dyspnea or anginal pain
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial is testing two specific breathing techniques — alternate nostril breathing and bellows breath — for COPD. Do you think either of these techniques could be appropriate for my current lung function and COPD severity?
2The trial is measuring FEV₁, FVC, and the FEV₁/FVC ratio, which are the same lung function tests used to diagnose my COPD — do you think my baseline numbers suggest I could realistically benefit from a breathing exercise intervention like this?
3Since the trial isn't recruiting yet, there's no published safety or outcome data from this specific study — are there existing studies on these yoga breathing techniques in COPD patients that you'd feel comfortable sharing with me so we can discuss what's already known?
4This study is listed as Phase NA, which typically means it's a non-drug intervention study — does that change how you weigh the risk level compared to a standard drug trial, and would participating in something like this interfere with my current COPD treatment plan?
5Would it make more sense for me to focus on standard COPD management first, such as pulmonary rehabilitation or medication optimization, rather than waiting to see if this trial opens enrollment?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Forced Vital Capacity
Timeframe: Baseline and after 4 weeks of intervention
2
Forced Expiratory Volume in One Second
Timeframe: Baseline and after 4 weeks of intervention
3
FEV₁/FVC ratio
Timeframe: Baseline and after 4 weeks of intervention
4
Health-Related Quality of Life
Timeframe: Baseline and after 4 weeks of intervention